Roundhill Daily 2X Long Magnificent Seven ETFMAGX

The Roundhill Daily 2X Long Magnificent Seven ETF (MAGX) has surged in popularity as a tool for aggressive equity exposure, but its reality is less glamorous than its name suggests. Listed on Nasdaq, MAGX aims to deliver twice the daily return of a basket of seven stocks, though the exact composition of this ‘Magnificent Seven’ is not publicly detailed in its SEC filings. The fund charges an annual fee of 0.95%, which FINRA’s Fund Analyzer notes is standard for concentrated ETFs, though the compounding effects of daily rebalancing often erode long-term returns.

At its core, MAGX is a wrapper around a mechanical process: it rebalances daily to maintain 2x leverage, using derivatives or futures to achieve target exposure. This mechanism introduces tracking error, as admitted in its prospectus, which warns that market volatility and trading costs may prevent perfect correlation with the underlying index. Roundhill’s marketing emphasizes ‘magnificent’ growth stories, but the fund’s actual holdings remain opaque, with no public breakdown of sector weights or specific stock allocations.

Source limitations are critical. The SEC’s EDGAR database provides MAGX’s prospectus and filings, but these lack granular performance data or detailed risk metrics. Nasdaq’s market activity page shows intraday pricing but no historical context. FINRA’s analyzer offers expense ratios and broad risk disclosures but no independent performance verification. What remains unproven is how MAGX behaves during prolonged market stress or high volatility-a scenario where concentrated ETFs historically lag their stated objectives.